ChatGPT will ‘better detect’ mental distress after reports of it feeding people’s delusions
OpenAI, which is expected to launch its GPT-5 AI model this week, is making updates to ChatGPT that…
Republicans want to give gig workers benefits. There’s a catch.
Should independent contractors get employment benefits? The question has fueled decades of legal and political battles — and…
Health Care Inc.: MAGA backs Medicare, faux drug price transparency
Bob Herman covers health insurance, government programs, hospitals, physicians, and other providers — reporting on how money influences…
Jobs report, financial numbers warning signs for Trump economy
President Donald Trump has promised an economic “golden age.” But a spate of weak indicators this week told…
Cardinal Health Foundation seeks to increase medication access in Ohio
Top headlines of the week, July 25 2025 Here are some stories you may have missed this week…
Google has just two weeks to begin cracking open Android, it admits in emergency filing
4. For a period of three years ending on November 1, 2027, Google may not share revenue generated…
DJI won’t sell you an Osmo 360 in the US — but these retailers will
We knew DJI had a hard time importing its drones into the United States to the point that…
Ready or not, age verification is rolling out across the internet
On July 25th, the UK became one of the first countries to widely implement age verification. Its Online…
What is 7-OH? Opioid-like product may get banned by FDA
The Food and Drug Administration (FDA) is recommending banning a compound found in unregulated tablets, gummies and drink…
Health care, tech companies promise to make patient data more accessible
Mario Aguilar covers technology in health care, including artificial intelligence, virtual reality, wearable devices, telehealth, and digital therapeutics.…
Opera is filing a complaint over Microsoft’s tricks that push you to use Edge
Microsoft has used a variety of tricks to convince people to keep using the defaults of Bing and…
Vinay Prasad departs FDA | STAT
Adam Feuerstein is a senior writer and biotech columnist, reporting on the crossroads of drug development, business, Wall…